Clavusef 500 mg

Cefuroxime Axetil + Clavulanic Acid

Category: Antibiotic (Beta-Lactam/Beta-Lactamase Inhibitor)

Composition:

• Cefuroxime Axetil (500 mg): A second-generation cephalosporin that inhibits bacterial cell wall synthesis, effectively combating a wide range of bacterial infections.
• Clavulanic Acid: A beta-lactamase inhibitor that prevents bacterial resistance, enhancing the efficacy of cefuroxime.

Indications:
Clavusef 500 is indicated for:

• Respiratory tract infections (sinusitis, pneumonia, bronchitis)
• Urinary tract infections (UTIs)
• Skin and soft tissue infections
• Ear infections (otitis media)
• Throat infections (pharyngitis, tonsillitis)

Key Features:

• Broad-spectrum antibacterial action
• Beta-lactamase resistance for better efficacy
• Higher strength for severe infections

Dosage:

• Adults: Usually 1 tablet (500 mg) twice daily or as prescribed by a physician.
• Children: Dosage based on weight, as directed by a doctor.

Precautions:

• Avoid in patients allergic to cephalosporins or beta-lactams.
• Use with care in cases of renal impairment.
• Report any allergic reactions or severe side effects to a healthcare provider.

Storage:
Store in a dry place below 25°C, away from direct light and moisture.

Presentation:
Clavusef 500 is available in blister packs of 10 tablets.

Note: Use Clavusef 500 only under medical supervision to prevent antibiotic resistance.